1. Home
  2. ADXN vs SNGX Comparison

ADXN vs SNGX Comparison

Compare ADXN & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • SNGX
  • Stock Information
  • Founded
  • ADXN 2002
  • SNGX 1987
  • Country
  • ADXN Switzerland
  • SNGX United States
  • Employees
  • ADXN N/A
  • SNGX N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADXN Health Care
  • SNGX Health Care
  • Exchange
  • ADXN Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • ADXN 8.0M
  • SNGX 7.4M
  • IPO Year
  • ADXN N/A
  • SNGX 1987
  • Fundamental
  • Price
  • ADXN $7.74
  • SNGX $2.35
  • Analyst Decision
  • ADXN Strong Buy
  • SNGX
  • Analyst Count
  • ADXN 1
  • SNGX 0
  • Target Price
  • ADXN $30.00
  • SNGX N/A
  • AVG Volume (30 Days)
  • ADXN 31.1K
  • SNGX 621.7K
  • Earning Date
  • ADXN 03-24-2025
  • SNGX 03-14-2025
  • Dividend Yield
  • ADXN N/A
  • SNGX N/A
  • EPS Growth
  • ADXN N/A
  • SNGX N/A
  • EPS
  • ADXN 0.06
  • SNGX N/A
  • Revenue
  • ADXN $701,260.00
  • SNGX $364,183.00
  • Revenue This Year
  • ADXN N/A
  • SNGX N/A
  • Revenue Next Year
  • ADXN N/A
  • SNGX $76.64
  • P/E Ratio
  • ADXN $1.03
  • SNGX N/A
  • Revenue Growth
  • ADXN N/A
  • SNGX N/A
  • 52 Week Low
  • ADXN $6.81
  • SNGX $1.83
  • 52 Week High
  • ADXN $27.90
  • SNGX $14.88
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.97
  • SNGX 38.58
  • Support Level
  • ADXN $7.20
  • SNGX $2.16
  • Resistance Level
  • ADXN $8.04
  • SNGX $2.63
  • Average True Range (ATR)
  • ADXN 0.51
  • SNGX 0.17
  • MACD
  • ADXN 0.00
  • SNGX 0.01
  • Stochastic Oscillator
  • ADXN 47.95
  • SNGX 36.54

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: